A pragmatic trial with an optimized dose of rifampicin and moxifloxacin for the treatment of drug-susceptible pulmonary tuberculosis: a study protocol for open-label, randomized phase III trial (OptiRiMoxTB)
一项针对药物敏感性肺结核的利福平和莫西沙星优化剂量实用性试验:一项开放标签、随机 III 期试验的研究方案 (OptiRiMoxTB)
期刊:Trials
影响因子:2
doi:10.1186/s13063-026-09466-0
Mlyuka, Hamu J; Liyoyo, Alphonce; Nyaulingo, Belinda; Mpolya, Emmanuel; Kaswaga, Oscar L; Semvua, Hadija; Lwambura, Samwel; McHugh, Tim D; Wildner, Leticia; Sabiiti, Wilber; Adegbite, Bayode R; Nliwasa, Marriot; Khosa, Celso; Mbelele, Peter; Mbeya, Benno; Jeremiah, Kidola; Boeree, Martin J; Gillespie, Stephen H; Sloan, Derek J; Mpagama, Stellah G